Efficacy and toxicity of ipilimumab used after nivolumab in patients with melanoma.
作者信息
Sato Misato, Uhara Hisashi, Koga Hiroshi, Okuyama Ryuhei
机构信息
Department of Dermatology, Shinshu University School of Medicine, Nagano, Japan.
Department of Dermatology, Sapporo Medical University, Hokkaido, Japan.
出版信息
J Dermatol. 2018 Oct;45(10):e287-e289. doi: 10.1111/1346-8138.14325. Epub 2018 Apr 14.
PMID:29655228
Abstract
摘要
相似文献
1
Efficacy and toxicity of ipilimumab used after nivolumab in patients with melanoma.纳武单抗治疗后使用伊匹木单抗治疗黑色素瘤患者的疗效和毒性
J Dermatol. 2018 Oct;45(10):e287-e289. doi: 10.1111/1346-8138.14325. Epub 2018 Apr 14.
2
Type 1 diabetes in a melanoma patient treated with ipilimumab after nivolumab.一名黑色素瘤患者在接受纳武单抗治疗后使用伊匹单抗治疗时发生1型糖尿病。
J Dermatol. 2018 Oct;45(10):e289-e290. doi: 10.1111/1346-8138.14331. Epub 2018 Apr 18.
3
Secondary haemophagocytic lymphohistiocytosis due to checkpoint inhibitor therapy.检查点抑制剂治疗所致继发性噬血细胞性淋巴组织细胞增生症
Eur J Cancer. 2019 Jul;115:84-87. doi: 10.1016/j.ejca.2019.04.026. Epub 2019 May 23.
4
Investigation of clinical factors associated with longer overall survival in advanced melanoma patients treated with sequential ipilimumab.探究与接受序贯伊匹单抗治疗的晚期黑色素瘤患者更长总生存期相关的临床因素。
J Dermatol. 2019 Jun;46(6):498-506. doi: 10.1111/1346-8138.14865. Epub 2019 Apr 4.
5
Evaluation of Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma: Results From the Phase IIIb/IV CheckMate 511 Trial.评估纳武利尤单抗联合伊匹木单抗用于晚期黑色素瘤患者的两种剂量方案：来自 IIIb/IV 期 CheckMate 511 试验的结果。
J Clin Oncol. 2019 Apr 10;37(11):867-875. doi: 10.1200/JCO.18.01998. Epub 2019 Feb 27.
6
Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study.纳武利尤单抗联合伊匹单抗或纳武利尤单抗单药治疗黑色素瘤脑转移瘤：一项多中心随机 2 期研究。
Lancet Oncol. 2018 May;19(5):672-681. doi: 10.1016/S1470-2045(18)30139-6. Epub 2018 Mar 27.
7
Fulminant response to combined checkpoint inhibition with ipilimumab plus nivolumab after failure of nivolumab monotherapy in metastatic melanoma.在转移性黑色素瘤中，纳武单抗单药治疗失败后，伊匹单抗联合纳武单抗进行联合检查点抑制治疗出现暴发性反应。
Eur J Cancer. 2017 Sep;83:142-145. doi: 10.1016/j.ejca.2017.06.020. Epub 2017 Jul 20.
8
Bullous pemphigoid induced by ipilimumab in a patient with metastatic malignant melanoma after unsuccessful treatment with nivolumab.一名转移性恶性黑色素瘤患者在使用纳武单抗治疗失败后，因使用伊匹单抗诱发大疱性类天疱疮。
J Dermatol. 2018 Jan;45(1):e21-e22. doi: 10.1111/1346-8138.14043. Epub 2017 Sep 25.
9
Nivolumab plus ipilimumab in metastatic colorectal cancer.纳武利尤单抗联合伊匹木单抗治疗转移性结直肠癌
Lancet Oncol. 2018 Mar;19(3):e139. doi: 10.1016/S1470-2045(18)30067-6. Epub 2018 Jan 26.
10
Infliximab for severe colitis associated with nivolumab followed by ipilimumab.英夫利昔单抗用于治疗与纳武单抗随后伊匹单抗相关的严重结肠炎。
J Dermatol. 2018 Jan;45(1):e1-e2. doi: 10.1111/1346-8138.14034. Epub 2017 Sep 11.
Zotero 插件